Xponance, Inc. Invitae Corp Transaction History

Xponance, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	BUY	$1.05 - $1.63 $1,487 - $2,309	1,417 Added 10.19%	15,323 $17,000
Q4 2022 Jan 23, 2023	BUY	$1.71 - $3.61 $1,065 - $2,249	623 Added 4.69%	13,906 $0
Q3 2022 Oct 24, 2022	BUY	$1.9 - $8.63 $1,932 - $8,776	1,017 Added 8.29%	13,283 $33,000
Q2 2022 Aug 02, 2022	BUY	$2.13 - $9.01 $26,126 - $110,516	12,266 New	12,266 $30,000
Q4 2021 Jan 31, 2022	SELL	$14.7 - $28.67 $138,062 - $269,268	-9,392 Closed	0 $0
Q3 2021 Nov 05, 2021	SELL	$24.31 - $33.6 $38,409 - $53,088	-1,580 Reduced 14.4%	9,392 $267,000
Q2 2021 Aug 12, 2021	BUY	$26.09 - $40.4 $286,259 - $443,268	10,972 New	10,972 $370,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.